FOLD vs. CMC

Last updated Apr 1, 2026

Compare and contrast key facts about Amicus Therapeutics, Inc. (FOLD) and Commercial Metals Company (CMC).

Performance

FOLD vs. CMC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amicus Therapeutics, Inc. (FOLD) and Commercial Metals Company (CMC). The values are adjusted to include any dividend payments, if applicable.

FOLD vs. CMC - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
FOLD Amicus Therapeutics, Inc.	1.54%	51.17%	-33.62%	16.22%	5.71%	-49.98%	137.06%	1.67%	-33.43%	189.54%
CMC Commercial Metals Company	-11.04%	41.52%	0.41%	4.99%	35.05%	79.83%	-5.45%	42.81%	-23.17%	0.33%

Fundamentals

Market Cap FOLD : $4.55B CMC : $6.89B
EPS FOLD : -$0.09 CMC : $4.48
PS Ratio FOLD : 7.09 CMC : 0.83
PB Ratio FOLD : 16.58 CMC : 1.56
Total Revenue (TTM) FOLD : $634.21M CMC : $8.39B
Gross Profit (TTM) FOLD : $561.28M CMC : $1.49B
EBITDA (TTM) FOLD : $42.38M CMC : $905.85M

Returns By Period

In the year-to-date period, FOLD achieves a 1.54% return, which is significantly higher than CMC's -11.04% return. Over the past 10 years, FOLD has underperformed CMC with an annualized return of 5.22%, while CMC has yielded a comparatively higher 15.89% annualized return.

FOLD

• 1D: 0.21%
• 1M: 0.63%
• YTD: 1.54%
• 6M: 83.50%
• 1Y: 77.21%
• 3Y*: 9.25%
• 5Y*: 7.53%
• 10Y*: 5.22%

CMC

• 1D: 2.23%
• 1M: -16.19%
• YTD: -11.04%
• 6M: 7.82%
• 1Y: 34.71%
• 3Y*: 9.21%
• 5Y*: 16.31%
• 10Y*: 15.89%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

FOLD vs. CMC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FOLD

FOLD Risk / Return Rank: 84
FOLD Sharpe Ratio Rank: 86
FOLD Sortino Ratio Rank: 88
FOLD Omega Ratio Rank: 90
FOLD Calmar Ratio Rank: 80
FOLD Martin Ratio Rank: 77

CMC

CMC Risk / Return Rank: 70
CMC Sharpe Ratio Rank: 73
CMC Sortino Ratio Rank: 68
CMC Omega Ratio Rank: 67
CMC Calmar Ratio Rank: 66
CMC Martin Ratio Rank: 74

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FOLD vs. CMC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Amicus Therapeutics, Inc. (FOLD) and Commercial Metals Company (CMC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	FOLD	CMC	Difference
Sharpe ratio Return per unit of total volatility	1.63	0.93	+0.70
Sortino ratio Return per unit of downside risk	2.67	1.47	+1.20
Omega ratio Gain probability vs. loss probability	1.40	1.19	+0.21
Calmar ratio Return relative to maximum drawdown	2.32	1.16	+1.16
Martin ratio Return relative to average drawdown	5.16	4.26	+0.90
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

FOLD vs. CMC - Sharpe Ratio Comparison

The current FOLD Sharpe Ratio is 1.63, which is higher than the CMC Sharpe Ratio of 0.93. The chart below compares the historical Sharpe Ratios of FOLD and CMC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	FOLD	CMC	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.63	0.93	+0.70
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.16	0.46	-0.30
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.09	0.40	-0.31
Sharpe Ratio (All Time) Calculated using the full available price history	0.00	0.35	-0.35

Correlation

The correlation between FOLD and CMC is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

FOLD vs. CMC - Dividend Comparison

FOLD has not paid dividends to shareholders, while CMC's dividend yield for the trailing twelve months is around 0.88%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
FOLD Amicus Therapeutics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
CMC Commercial Metals Company	0.88%	1.04%	1.41%	1.28%	1.20%	1.38%	2.34%	2.16%	3.00%	2.25%	2.20%	3.51%

Drawdowns

FOLD vs. CMC - Drawdown Comparison

The maximum FOLD drawdown since its inception was -89.91%, which is greater than CMC's maximum drawdown of -83.77%. Use the drawdown chart below to compare losses from any high point for FOLD and CMC.

Drawdown Indicators

	FOLD	CMC	Difference
Max Drawdown Largest peak-to-trough decline	-89.91%	-83.77%	-6.14%
Max Drawdown (1Y) Largest decline over 1 year	-29.50%	-29.96%	+0.46%
Max Drawdown (5Y) Largest decline over 5 years	-61.16%	-37.63%	-23.53%
Max Drawdown (10Y) Largest decline over 10 years	-77.34%	-53.78%	-23.56%
Current Drawdown Current decline from peak	-41.90%	-26.17%	-15.73%
Average Drawdown Average peak-to-trough decline	-53.81%	-23.56%	-30.25%
Ulcer Index Depth and duration of drawdowns from previous peaks	13.86%	8.16%	+5.70%

Volatility

FOLD vs. CMC - Volatility Comparison

The current volatility for Amicus Therapeutics, Inc. (FOLD) is 0.56%, while Commercial Metals Company (CMC) has a volatility of 12.87%. This indicates that FOLD experiences smaller price fluctuations and is considered to be less risky than CMC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	FOLD	CMC	Difference
Volatility (1M) Calculated over the trailing 1-month period	0.56%	12.87%	-12.31%
Volatility (6M) Calculated over the trailing 6-month period	30.44%	25.83%	+4.61%
Volatility (1Y) Calculated over the trailing 1-year period	47.84%	37.61%	+10.23%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	47.15%	35.54%	+11.61%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	55.54%	39.65%	+15.89%

Financials

FOLD vs. CMC - Profitability Comparison

The chart below illustrates the profitability comparison between Amicus Therapeutics, Inc. and Commercial Metals Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

FOLD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Amicus Therapeutics, Inc. reported a gross profit of 160.54M and revenue of 185.21M. Therefore, the gross margin over that period was 86.7%.

CMC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Commercial Metals Company reported a gross profit of 387.91M and revenue of 2.13B. Therefore, the gross margin over that period was 18.2%.

FOLD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Amicus Therapeutics, Inc. reported an operating income of 15.95M and revenue of 185.21M, resulting in an operating margin of 8.6%.

CMC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Commercial Metals Company reported an operating income of 154.74M and revenue of 2.13B, resulting in an operating margin of 7.3%.

FOLD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Amicus Therapeutics, Inc. reported a net income of 1.69M and revenue of 185.21M, resulting in a net margin of 0.9%.

CMC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Commercial Metals Company reported a net income of 93.03M and revenue of 2.13B, resulting in a net margin of 4.4%.